Ovalbumin-specific adaptive immune receptors (OVA-specific TCR/BCR)

Ovalbumin-specific adaptive immune receptors are a class of T-cell receptors (TCRs) and B-cell receptors (BCRs) that specifically recognize peptides or epitopes derived from ovalbumin, the major protein found in avian egg whites (UniProt P01012). These receptors are primarily used as fundamental tools in immunological research to track and manipulate antigen-specific immune responses in vivo and in vitro. The most prominent examples include the OT-I and OT-II transgenic systems, which provide a population of T cells with uniform specificity for ovalbumin-derived peptides, such as the MHC class I-restricted SIINFEKL peptide (Hogquist et al., 1994; Barnden et al., 1998). While these receptors are not targets for conventional drug therapy, they are central to the study of vaccine development, T-cell exhaustion, and the mechanisms of immune tolerance. In a clinical context, B-cell receptors (specifically IgE) specific for ovalbumin are the primary mediators of egg allergy, where their activation leads to mast cell degranulation and hypersensitivity reactions (NIAID). Researchers utilize these receptors to evaluate the efficacy of novel immunotherapies, such as checkpoint inhibitors, by observing the behavior of OVA-specific T cells in tumor models expressing ovalbumin as a surrogate neoantigen. Consequently, they serve as a gold standard for modeling adaptive immunity rather than acting as a direct site for pharmacological intervention.

Other names

Ovalbumin-specific T-cell receptorOvalbumin-specific B-cell receptorOT-I TCROT-II TCROVA-specific TCR

Not applicable as this refers to a research model system rather than a therapeutic drug target.